Bronstein, Gewirtz & Grossman LLC Urges Regeneron Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
· llc, bronstein, gewirtz & grossman
AI Briefing
- • Regeneron Pharmaceuticals, Inc. investors urged to seek recovery for alleged securities fraud.
- • Lead plaintiff deadline for class action is September 14, 2026.
- • Deadline only available in paid plans, not publicly disclosed.
Source Summary
New class action for Regeneron (REGN) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 9/14/2026
Advertisement